Ketamine-Induced Mania During Treatment for Complex Regional Pain Syndrome
Mala C. Mandyam, Neera K. Ahuja
Pain Medicine March 10, 2017 DOI: 10.1093/pm/pnx061 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | 30-year-old woman with complex regional pain syndrome of the right lower extremity and depression |
| Intervention | Ketamine |
| Topics | Esketamine Ketamine |
| Citations | 10 |
| Key findings | The authors report that a ketamine infusion for CRPS in a young woman with depression induced a prolonged manic episode and may have unmasked bipolar disorder. They note that few other case reports have documented similar prolonged exacerbations of underlying mood disorders after ketamine administration. |
Abstract
Dear Editor, Complex regional pain syndrome (CRPS) describes a disease of localized chronic pain that often occurs after preceding trauma, is out of proportion to its expected course, and includes other symptoms such as hair loss and allodynia [1]. There are no known psychologic or personality factors associated with its development [2]. Therapy is multimodal, and pharmacologic treatments include steroids, antiepileptics, antidepressants, opiates, and ketamine [3]. Ketamine is mainly an N-methyl-D-aspartate (NMDA) receptor antagonist with known psychomimetic effects that are usually transient, mild, and tolerable [4]. We describe a case of ketamine inducing a prolonged manic episode and potentially unmasking bipolar disorder in a young woman with depression and CRPS. Few other case reports have documented similar prolonged exacerbations of underlying mood disorders post–ketamine administration. Our patient is a 30-year-old female who was admitted to the inpatient pain service for ketamine infusion for right lower extremity CRPS. She sustained a right foot sprain during laser tag three years prior. She developed constant pain that was aggravated by touch, temperature changes, and humidity. She tried physical therapy, group psychotherapy, pregabalin, mexiletine, gabapentin, and an epidural injection with little effect. Intravenous (IV) lidocaine previously provided only temporary relief, and a spinal cord stimulator failed after six weeks. Opiates previously helped, but she developed opioid use disorder, for which she was undergoing treatment.
Comparable studies
Other case reports and case series on ketamine, most cited first.
Citations in the library
Cited by 5
- Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review Frontiers in Psychiatry June 3, 2020
- Ketamine and chronic treatment-resistant depression: real-world practice and after relapse. BMC Psychiatry October 28, 2024
- Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway Zoological Research November 18, 2022
- Efficacy of ketamine for comorbid depression and acute or chronic pain: A systematic review. Frontiers in Pain Research 2022
- Chronic lithium exposure attenuates ketamine-induced mania-like behavior and c-Fos expression in the forebrain of mice. Pharmacology, Biochemistry, and Behavior January 12, 2021